Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
European Journal of Medicinal Chemistry
|
January 6, 2016
Benzamide derivatives and their constrained analogs as histamine H3 receptor antagonists
Ramakrishna Nirogi, Anil Shinde, Vinaykumar Tiriveedhi, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 8, 2010
Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists
Ramakrishna V S Nirogi, Amol D Deshpande, Ramasastri Kambhampati, et al.
International Journal of Geriatric Psychiatry
|
September 28, 2022
Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses
Ramakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Vijay Benade, Anil Shinde, Rajesh Kumar Badange, et al.
Journal of Medicinal Chemistry
|
February 18, 2017
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT<sub>6</sub>) Receptor Antagonist for Potential Treatment of Alzheimer's Disease
Ramakrishna Nirogi, Anil Shinde, Rama Sastry Kambhampati, et al.
Journal of Medicinal Chemistry
|
January 11, 2019
Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H<sub>3</sub> Receptor Inverse Agonist with Robust Wake-Promoting Activity
Ramakrishna Nirogi, Anil Shinde, Abdul Rasheed Mohammed, et al.
Chemmedchem
|
November 11, 2021
1-[2-(1-Cyclobutylpiperidin-4-yloxy)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]propan-1-one: a Histamine H<sub>3</sub> Receptor Inverse Agonist with Efficacy in Animal Models of Cognition
Anil Karbhari Shinde, Rajesh Kumar Badange, Veena Reballi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Renny Abraham, Venkatesh Goura, Rajesh Kallepalli, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
European Journal of Medicinal Chemistry
|
January 6, 2016
Benzamide derivatives and their constrained analogs as histamine H3 receptor antagonists
Ramakrishna Nirogi, Anil Shinde, Vinaykumar Tiriveedhi, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 8, 2010
Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists
Ramakrishna V S Nirogi, Amol D Deshpande, Ramasastri Kambhampati, et al.
International Journal of Geriatric Psychiatry
|
September 28, 2022
Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses
Ramakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Vijay Benade, Anil Shinde, Rajesh Kumar Badange, et al.
Journal of Medicinal Chemistry
|
February 18, 2017
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT<sub>6</sub>) Receptor Antagonist for Potential Treatment of Alzheimer's Disease
Ramakrishna Nirogi, Anil Shinde, Rama Sastry Kambhampati, et al.
Journal of Medicinal Chemistry
|
January 11, 2019
Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H<sub>3</sub> Receptor Inverse Agonist with Robust Wake-Promoting Activity
Ramakrishna Nirogi, Anil Shinde, Abdul Rasheed Mohammed, et al.
Chemmedchem
|
November 11, 2021
1-[2-(1-Cyclobutylpiperidin-4-yloxy)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]propan-1-one: a Histamine H<sub>3</sub> Receptor Inverse Agonist with Efficacy in Animal Models of Cognition
Anil Karbhari Shinde, Rajesh Kumar Badange, Veena Reballi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Renny Abraham, Venkatesh Goura, Rajesh Kallepalli, et al.
Page
of 1